BlackRock Institutional Trust’s aTyr Pharma ATYR Stock Holding History

BlackRock Institutional Trust’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$762K	Buy	25,325 +721	+3%	+$29.6K	﹤0.01%	3361
2016 Q3	$1.09M	Buy	24,604 +17	+0.1%	+$735	﹤0.01%	3256
2016 Q2	$957K	Buy	24,587 +18,697	+317%	+$869K	﹤0.01%	3318
2016 Q1	$325K	Sell	5,890 -66	-1%	-$5.02K	﹤0.01%	3539
2015 Q4	$820K	Buy	5,956 +119	+2%	+$16.9K	﹤0.01%	3377
2015 Q3	$838K	Buy	5,837 +3,090	+112%	+$704K	﹤0.01%	3387
2015 Q2	$712K	Buy	+2,747	New	+$853K	﹤0.01%	3439

Other funds holding ATYR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

GHCM

Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return

MCIM

Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return

BlackRock Institutional Trust's ATYR Position: Q4 2016 in Review

BlackRock Institutional Trust increased its aTyr Pharma (ATYR) stake by 2.9% in Q4 2016, buying an estimated $29.6K and bringing the position to 25,325 shares worth $762K. The position accounts for ﹤0.01% of the portfolio, ranked #3361.

BlackRock Institutional Trust first reported a position in ATYR in Q2 2015 and has held it in 7 quarters since. The position peaked at $1.09M in Q3 2016. 52 funds tracked by Wall St. Rank hold ATYR as of Q4 2016.

BlackRock Institutional Trust held 25,325 shares of aTyr Pharma worth $762K as of Q4 2016.
BlackRock Institutional Trust bought 721 aTyr Pharma shares in Q4 2016, an estimated $29.6K.
aTyr Pharma made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3361 holding.
BlackRock Institutional Trust first reported a position in aTyr Pharma in Q2 2015 and has held it in 7 quarters since.
BlackRock Institutional Trust's aTyr Pharma position peaked at $1.09M in Q3 2016.
52 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.